Fallopian Tube Carcinoma — Trials

Fallopian Tube Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

213 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 77
Recruiting: 29
Ph III recruiting: 4
Growth YoY: —
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02125513	Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer(GOGER-01)	unknown	Phase 2	129	IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER	1	Dec 30, 2022	clinicaltrials
NCT02033616	Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Advanced Epithelial Ovarian Carcinomas	unknown	Phase 2	99	Aivita Biomedical, Inc.INDUSTRY	1	Apr 25, 2022